Area of Research: Therapeutic Targeting

2019 Grant Recipients

• Isaac Klein, MD, PhD, Dana Farber Cancer Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Transcriptional Regulatory Landscape of High Grade Serous Ovarian Cancer
• Xiaowen Hu, PhD, University of Pennsylvania
  Liz Tilberis Early Career Award
  Targeting Chromatin Remodeling Complex to Treat Ovarian Cancer
• Kate Lawrenson, PhD, Cedars-Sinai Medical Center
  Liz Tilberis Early Career Award
  Elucidating the Role of SOX17 in HGSOC
• Ronald Buckanovich, MD, PhD, Magee-Womens Research Institute
  Collaborative Research Development Grant
  Targeting Tumor Desmoplasia to Enhance Immunotherapy

2017 Grant Recipients

• Nabanita Chatterjee, PhD, MD Anderson Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Ovarian Cancer Disrupts Circadian Cortisol Rhythms
• Jagmohan Hooda, PhD, University of Pennsylvania
  Ann and Sol Schreiber Mentored Investigator Award
  Loss of H2Bub1 Rewires Glutamine Metabolism During Progression of HGSOC
• Dongyu Jia, PhD, Cedars-Sinai Medical Center
  Ann and Sol Schreiber Mentored Investigator Award
  COL11A Is A Highly Specific Therapeutic Target in Cancer-Activated Stroma
• Ronen Marmorstein, PhD, University of Pennsylvania
  Collaborative Research Development Grant
  Chromatin Regulatory Mechanisms in Ovarian Cancer

2016 Grant Recipients

• Fan Zhao, PhD, Stanford University
  Ann and Sol Schreiber Mentored Investigator Award
  Ovarian Cancer Antigen Discovery by Single t-cell Analysis and pHLA Library

2015 Grant Recipients

• Alfredo Perales-Puchalt, MD, The Wistar Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Targeting FSH Receptor with Chimeric Antigen Receptor in Ovarian Cancer

2014 Grant Recipients

• Rachel Grisham, MD, Memorial Sloan Kettering Cancer Center
  Liz Tilberis Early Career Award
  Determining the Molecular Drivers of Low-Grade Serous Ovarian Cancer
• Selvendiran Karuppaiyah, PhD, Ohio State University
  Liz Tilberis Early Career Award
  New Type of Experimental Drug for Ovarian Cancer
• Ilana Chefetz, PhD, University of Michigan
  Ann and Sol Schreiber Mentored Investigator Award
  A Role for ALDH in the Regulation of Necroptosis in Ovarian Cancer Area of research: Therapeutic Targeting
• Kyung Hee Noh, PhD, MD Anderson Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Targeting Adaptive Changes to anti-VEGF Therapy in Ovarian Cancer
• Shailja Pathania, PhD, Dana Farber Cancer Institute
  Ann and Sol Schreiber Mentored Investigator Award
  Novel Therapeutic Targets for High-Grade Serous Ovarian Carcinoma

2013 Grant Recipients

• Maria Barbolina, PhD, University of Illinois - Chicago
  Liz Tilberis Early Career Award
  Chemokine-Dependent Control of Survival in Ovarian Carcinoma
• Stephanie Gaillard, MD, PhD, Duke Cancer Institute
  Liz Tilberis Early Career Award
  Evaluating ERRalpha as a Novel Therapeutic Target in Ovarian Cancer
• Teng Ma, MD, PhD, University of Michigan - Ann Arbor
  Ann and Sol Schreiber Mentored Investigator Award
  The Analysis of NEDD8-activating Enzyme Inhibitor MLN4924 on Ovarian Cancer
• Xin Huang, PhD, Magee-Womens Research Institute
  Liz Tilberis Early Career Award
  Noval Strategy of Metabolic Targeting Ovarian Cancer: Focusing on the Tumor Hypoxia Pathway
• Mythreye Karthikeyan, PhD, University of South Carolina
  Liz Tilberis Early Career Award
  Investigating the TGFß Superfamily as Therapeutic Targets in Ovarian Cancer
• Joyce Liu, MD, MPH, Dana Farber Cancer Institute
  Liz Tilberis Early Career Award
  Investigating ErbB3 as a Novel Therapeutic Target in Ovarian Cancer
• Yin Wang, PhD, Mayo Clinic Jacksonville
  Ann and Sol Schreiber Mentored Investigator Award
  Protein Kinase C iota is a Novel Therapeutic Target for Ovarian Cancer Treatment

2012 Grant Recipients

• Bin Guan, PhD, Johns Hopkins University School of Medicine
  Ann and Sol Schreiber Mentored Investigator Award
  Functional Characterization of the Tumor Suppressor ARID1A in Ovarian Cancer
• Karen Cowden Dahl, PhD, Indiana University
  Liz Tilberis Early Career Award
  Investigation of ARID3B Splicing as a Novel Therapeutic Target for Ovarian Cancer
• Hanqing Liu, PhD, Fox Chase Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Targeting Signaling Networks via RNAi to Improve Therapy for Ovarian Cancer
• W. Ruprecht Wiedemeyer, PhD, Cedars-Sinai Medical Center
  Liz Tilberis Early Career Award
  Ovarian Cancer Evolution After Targeted Therapy

2011 Grant Recipients

• Santo Nicosia, MD, University South Florida
  Collaborative Research Development Grant
  Ovarian Cancer: A Theme Based Approach Toward Identification of Novel Diagnostic and Therapeutic Targets
• Sherry Wu, PhD, MD Anderson Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Novel Approach to Destroy the Blood Supply that Feeds Ovarian Cancer Tumors
• Selvendiran Karuppaiyah, PhD, Ohio State University
  Liz Tilberis Early Career Award
  Safe, Targeted, Antitumor Therapeutics (STAT3 Inhibitors) for Ovarian Cancer

2008 Grant Recipients

• Takayo Ota, MD, PhD, Mayo Clinic Rochester
  Ann and Sol Schreiber Mentored Investigator Award
  Characterizing the Genetic Alterations of Aggressive Ovarian Cancer
• Thuy-Vy Do, PhD, Fox Chase Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Understanding How Ovarian Cancer Spreads

2007 Grant Recipients

• Martin Matthew Matzuk, MD, PhD, Baylor College of Medicine
  Collaborative Research Development Grant
  MicroRNA’s as Diagnostic and Therapeutic Targets in Ovarian Cancer
• Mitchell Cheung, PhD, Fox Chase Cancer Center
  Ann and Sol Schreiber Mentored Investigator Award
  Testing New Therapeutic Agents to Treat Ovarian Cancer

2005 Grant Recipients

• Anil K. Sood, MD, MD Anderson Cancer Center
  Collaborative Research Development Grant
  Novel siRNA Based Therapeutic Approaches for Ovarian Carcinoma
• Andrew K. Godwin, PhD, Fox Chase Cancer Center
  Collaborative Research Development Grant
  Therapeutic Targeting of the Tumor Microenvironment in Ovarian Cancer

2004 Grant Recipients

• Ernst Lengyel, MD, PhD, University of Chicago
  Liz Tilberis Early Career Award
  Role and Regulation of Hepatocyte Growth Factor and c-Met in Ovarian Cancer

2001 Grant Recipients

• Kimberly Kalli, PhD, Mayo Clinic
  Liz Tilberis Early Career Award
  Functional Significance of Insulin Receptors in Epithelial Ovarian Cancer: Therapeutic Implications